Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Icahn School of Medicine at Mount Sinai
Celgene
US Oncology Research
University of Miami
National Cancer Institute (NCI)